Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Chuikyo Listens to NHI Drug Pricing Organization on Problems with NHI Pricing Rule
July 4, 2005
- NHO to Revise Its Clinical Trial Cost Calculation Method
July 4, 2005
- STATISTICS
July 4, 2005
- Let the Market Decide Prices of New Drugs: Mr Niwa
July 4, 2005
- SELF-MEDICATION NEWS IN BRIEF
July 4, 2005
- MEDICAL DEVICE NEWS IN BRIEF
July 4, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 4, 2005
- NEW PRODUCTS
July 4, 2005
- R&D NEWS IN BRIEF
July 4, 2005
- PEG-IFN + Ribavirin Effective against Hepatitis C: Society Meeting
July 4, 2005
- Large-scale Clinical Trial to Assess Primary Preventive Effects of Aspirin
July 4, 2005
- 7th Meeting of Japanese Society of Clinical Pharmacological Studies
July 4, 2005
- BUSINESS NEWS IN BRIEF
July 4, 2005
- Mr Niwa Presents His Views on Social Security Reform in Booklet
June 27, 2005
- OTC NEWS IN BRIEF
June 27, 2005
- 20 New Kit Products Added to NHI Price List
June 27, 2005
- Half of Glaucoma Patients Lack Subjective Symptoms: Survey
June 27, 2005
- FPMAJ Announces Its 2005 Report on NHI Pricing
June 27, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 27, 2005
- Gov't Approves 2005 White Paper on Aging Society
June 27, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…